| pubmed-article:20971977 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C1819440 | lld:lifeskim |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:20971977 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:20971977 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20971977 | pubmed:dateCreated | 2011-3-7 | lld:pubmed |
| pubmed-article:20971977 | pubmed:abstractText | Ulcerative colitis is associated with increased interleukin 13 (IL-13) production by natural killer T cells. Taking advantage of the inhibitory actions of interferon ? on IL-13 expression, this proof-of-concept study aimed to show that decreasing IL-13 production is associated with clinical improvement of ulcerative colitis symptoms. | lld:pubmed |
| pubmed-article:20971977 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20971977 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20971977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20971977 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20971977 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20971977 | pubmed:issn | 1468-3288 | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:FussIvan JIJ | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:StroberWarren... | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:MannonPeter... | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:YangZhiqiongZ | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:GrodenCatheri... | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:HornungRonald... | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:YiChuliC | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:FriendJuliaJ | lld:pubmed |
| pubmed-article:20971977 | pubmed:author | pubmed-author:YaoMichaelM | lld:pubmed |
| pubmed-article:20971977 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20971977 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:20971977 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20971977 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20971977 | pubmed:pagination | 449-55 | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:meshHeading | pubmed-meshheading:20971977... | lld:pubmed |
| pubmed-article:20971977 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20971977 | pubmed:articleTitle | Suppression of inflammation in ulcerative colitis by interferon-?-1a is accompanied by inhibition of IL-13 production. | lld:pubmed |
| pubmed-article:20971977 | pubmed:affiliation | Mucosal Immunity Section, Laboratory of Host Defense, NIAID, NIH, Bethesda, Maryland, USA. pmannon@uab.edu | lld:pubmed |
| pubmed-article:20971977 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20971977 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:20971977 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| pubmed-article:20971977 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20971977 | lld:pubmed |
